πŸ‡ΊπŸ‡Έ FDA
Patent

US 10973844

TALEN-based gene correction

granted A61KA61K31/7088A61K31/713

Quick answer

US patent 10973844 (TALEN-based gene correction) held by Regents of the University of Minnesota expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7088, A61K31/713, A61P, A61P17/00